Update on Adjuvant Chemotherapy for Early Breast Cancer
Breast cancer is the second most common cancer in women worldwide. Although most women are diagnosed with early breast cancer, a substantial number recur due to persistent micro-metastatic disease. Systemic adjuvant chemotherapy improves outcomes and has advanced from first-generation regimens to mo...
Main Authors: | Murtuza M. Rampurwala, Gabrielle B. Rocque, Mark E. Burkard |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-01-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.4137/BCBCR.S9454 |
Similar Items
-
Update on Adjuvant Chemotherapy for Early Breast Cancer
by: Murtuza M. Rampurwala, et al.
Published: (2014-10-01) -
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer.
by: Ali Hajjar, et al.
Published: (2019-01-01) -
Updated Adjuvant Chemotherapy for Gastric Cancer
by: Toshizo Takayama, et al.
Published: (2023-10-01) -
Effects of Adjuvant Chemotherapy on Insulin Resistance in Patients with Early Breast Cancer
by: Izzet Doğan, et al.
Published: (2022-04-01) -
Cognitive function in women with early breast cancer receiving adjuvant chemotherapy
by: Lacey, RT, et al.
Published: (2006)